Basit öğe kaydını göster

dc.contributor.authorCetin, Meltem
dc.contributor.authorAktas, Yesim
dc.contributor.authorVural, Imran
dc.contributor.authorCapan, Yilmaz
dc.contributor.authorDogan, Lale A.
dc.contributor.authorDuman, Memed
dc.contributor.authorDalkara, Turgay
dc.date.accessioned2019-12-16T10:18:17Z
dc.date.available2019-12-16T10:18:17Z
dc.date.issued2007
dc.identifier.issn1071-7544
dc.identifier.urihttps://doi.org/10.1080/10717540701606483
dc.identifier.urihttp://hdl.handle.net/11655/20043
dc.description.abstractThe objective of our study was to prepare and characterize basic fibroblast growth factor (bFGF)-loaded nanoparticles. Protein-loaded chitosan nanoparticles were obtained by ionotropic gelation process based on the interaction between chitosan and tripolyphosphate (TPP). The protein-loading capacity and encapsulation efficiency were 0.021% and 27.388%, respectively. The bFGF-loaded nanoparticles have a mean diameter of 424 nm, a narrow size distribution, spherical shape and positive surface charges. In vitro release showed that the extent of release was 68% at 24 hr. The protein integrity was investigated by SDS-PAGE analysis that confirmed protein integrity was not affected by the encapsulation procedure and release conditions.
dc.language.isoen
dc.publisherTaylor & Francis Inc
dc.relation.isversionof10.1080/10717540701606483
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectPharmacology & Pharmacy
dc.titlePreparation and in Vitro Evaluation Of Bfgf-Loaded Chitosan Nanoparticles
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalDrug Delivery
dc.contributor.departmentFarmasötik Teknoloji
dc.identifier.volume14
dc.identifier.issue8
dc.identifier.startpage525
dc.identifier.endpage529
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster